OWL Genomics

OWL Genomics is a spin-off biotechnology company founded in 2002 with the aim of providing leading-edge applications in human health care, with innovative and pioneering technologies in the areas of diagnosis and treatment. The scientific expertise of Dr. José María Mato, and the studies that he has carried out during the last twenty years on hepatic diseases has placed OWL Genomics in a privileged position in the market of the hepatic diagnosis.

Our primary goal is the identification and validation of diagnostic biomarkers and therapeutic targets with the aim of developing diagnostic and treatment systems. To accomplish this we utilise innovative technology in genomics, proteomics, metabolomics and bioinformatics and have established a complete and highly productive platform which supports the advance of our developments.